Pilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma

Clinical trial NCT07712770 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07712770
Sponsor: Olivia Newton-John Cancer Research Institute
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Recurrent Glioblastoma IDH Wildtype Recurrent Glioblastoma

Start date: 2026-10-01
Primary completion: 2028-11-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.